World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
86
Citations
27712
World Ranking
2948
National Ranking
1510

Overview

Peter L. Pedersen is affiliated with Johns Hopkins University in the United States. Their research predominantly spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine, with a particular focus on subfields such as Cancer Research, Molecular Biology, Genetics, Pharmacology, and Physiology.

The scientist's work covers several main topics, including:

  • Venomous Animal Envenomation and Studies
  • Beetle Biology and Toxicology Studies
  • Healthcare and Venom Research
  • Pain Mechanisms and Treatments
  • Ion channel regulation and function
  • Neurobiology and Insect Physiology Research
  • Cancer, Hypoxia, and Metabolism

Among recent publications by Peter L. Pedersen are:

  • Pleiotropic Anticancer Properties of Scorpion Venom Peptides: Rhopalurus princeps Venom as an Anticancer Agent, 2020, Drug Design Development and Therapy
  • Piperine enhances contractile force in slow- and fast-twitch muscle, 2024, The Journal of Physiology
  • Cytoskeleton disruption by the metabolic inhibitor 3-bromopyruvate: implications in cancer therapy, 2022, Medical Oncology

Frequent co-authors collaborating with Peter L. Pedersen include:

  • Young Hee Ko
  • Arthur G Mikaelian
  • E. A. Traboulay
  • Xiaofei Michael Zhang
  • E. L. Yeritsyan

The most common venues for their publications are:

  • Drug Design Development and Therapy
  • The Journal of Physiology
  • Medical Oncology

Best Publications

  • Ion motive ATPases. I. Ubiquity, properties, and significance to cell function

    Peter L. Pedersen;Ernesto Carafoli

  • Tumor mitochondria and the bioenergetics of cancer cells.

    Peter L. Pedersen

  • Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria

    S P Mathupala;Y H Ko;P L Pedersen

  • The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane.

    R. R. H. Anholt;P. L. Pedersen;E. B. De Souza;S. H. Snyder

  • Defective protein folding as a basis of human disease

    Philip J. Thomas;Bao He Qu;Peter L. Pedersen

  • Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy.

    Saroj P. Mathupala;Young H. Ko;Peter L. Pedersen

  • Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the “Warburg Effect”, i.e., elevated glycolysis in the presence of oxygen

    Peter L. Pedersen

  • High aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinase

    Ernesto Bustamante;Peter L. Pedersen

  • Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver-derived tissues.

    Peter L. Pedersen;John W. Greenawalt;Baltazar Reynafarje;Joanne Hullihen

  • Glucose Catabolism in Cancer Cells IDENTIFICATION AND CHARACTERIZATION OF A MARKED ACTIVATION RESPONSE OF THE TYPE II HEXOKINASE GENE TO HYPOXIC CONDITIONS

    Saroj P. Mathupala;Annette Rempel;Peter L. Pedersen

  • Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP.

    Young H. Ko;Barbara L. Smith;Yuchuan Wang;Martin G. Pomper

  • Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP.

    K K Arora;P L Pedersen

  • Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention.

    Peter L Pedersen;Saroj Mathupala;Annette Rempel;J.F Geschwind

  • Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase.

    Young Hee Ko;Peter L. Pedersen;J.F. Geschwind

  • ATP Synthase and the Actions of Inhibitors Utilized To Study Its Roles in Human Health, Disease, and Other Scientific Areas

    Sangjin Hong;Peter L. Pedersen

  • Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding.

    E Bustamante;H P Morris;P L Pedersen

  • Aberrant glycolytic metabolism of cancer cells: A remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for Type II hexokinase

    Saroj P. Mathupala;Annette Rempel;Peter L. Pedersen

  • Glucose Catabolism in Cancer Cells.: ISOLATION, SEQUENCE, AND ACTIVITY OF THE PROMOTER FOR TYPE II HEXOKINASE *

    Saroj P. Mathupala;Annette Rempel;Peter L. Pedersen

  • Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.

    Jean Francois H. Geschwind;Young H. Ko;Michael S. Torbenson;Carolyn Magee

  • PROTON ATPASES: STRUCTURE AND MECHANISM

    L M Amzel;P L Pedersen

Frequent Co-Authors

Philip J. Thomas
Philip J. Thomas The University of Texas Southwestern Medical Center
L. Mario Amzel
L. Mario Amzel Johns Hopkins University School of Medicine
André Goffeau
André Goffeau Université Catholique de Louvain
Margarida Casal
Margarida Casal University of Minho
Harold P. Morris
Harold P. Morris Howard University
Wah Chiu
Wah Chiu Stanford University
William A. Catterall
William A. Catterall University of Washington
Albert S. Mildvan
Albert S. Mildvan Johns Hopkins University
Jeffrey C. Rathmell
Jeffrey C. Rathmell Vanderbilt University Medical Center
Anna Mae Diehl
Anna Mae Diehl Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Peter L. Pedersen

Trending Scientists